Evidence map›Paper›PMID 40563610›Full record

ArticleCancers2025

Race and Outcomes to [

Avina Rami, Caiwei Zhong, Miguel Muniz, Wanling Xie, Adam Khorasanchi, John Gallagher, Sedra Mohammadi, Daniel Fein, Andrew F Voter, Hailey Stoltenberg and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Avina RamiDana-Farber Cancer Institute, Boston, MA 02215, USA.
Caiwei ZhongDana-Farber Cancer Institute, Boston, MA 02215, USA.
Miguel MunizMayo Clinic, Rochester, MN 55905, USA.ORCID 0009-0004-7268-5077
Wanling XieDana-Farber Cancer Institute, Boston, MA 02215, USA.
Adam KhorasanchiDivision of Hospital Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.ORCID 0000-0002-4603-376X
John GallagherRoswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.
Sedra MohammadiMassachusetts General Hospital, Boston, MA 02214, USA.
Daniel FeinBeth Israel Deaconess Medical Center, Boston, MA 02215, USA.ORCID 0000-0003-4093-4863
Andrew F VoterJohns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Hailey StoltenbergDana-Farber Cancer Institute, Boston, MA 02215, USA.
Dharmesh GopalakrishanRoswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.
Yuanquan YangDivision of Hospital Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Thomas S C NgMassachusetts General Hospital, Boston, MA 02214, USA.ORCID 0000-0002-3676-1800
Andrei GafitaJohns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Daniel S ChildsMayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-7643-2836
Heather JaceneDana-Farber Cancer Institute, Boston, MA 02215, USA.
Praful RaviDana-Farber Cancer Institute, Boston, MA 02215, USA.

Funding

Conquer Cancer Foundation CDADana-Farber Cancer Institute MO Grant
6 · The paper itself

Abstract

Black patients with metastatic prostate cancer have higher mortality rates compared to non-Hispanic White patients. There are no data on outcomes with [

Indexed as

[177Lu]Lu-PSMA-617beta-emittercastration-resistant prostate cancerdisparitiesrace

Identifiers

PMID40563610
PMCPMC12191161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.